IQVIA (NYSE:IQV) Stock Sale Disclosed by Rep. Kevin Hern

Representative Kevin Hern (Republican-Oklahoma) recently sold shares of IQVIA Holdings Inc. (NYSE:IQV). In a filing disclosed on September 25th, the Representative disclosed that they had sold between $1,001 and $15,000 in IQVIA stock on September 3rd. The trade occurred in the Representative’s “KADEN EVERETT HERN TRUST” account.

Representative Kevin Hern also recently made the following trade(s):

• Sold $15,001 – $50,000 in shares of CenterPoint Energy (NYSE:CNP) on 9/15/2026.
• Sold $1,001 – $15,000 in shares of TJX Companies (NYSE:TJX) on 9/15/2026.
• Sold $15,001 – $50,000 in shares of STERIS (NYSE:STE) on 9/15/2026.
• Sold $1,001 – $15,000 in shares of Seagate Technology (NASDAQ:STX) on 9/15/2026.
• Sold $15,001 – $50,000 in shares of NextEra Energy (NYSE:NEE) on 9/14/2026.
• Sold $1,001 – $15,000 in shares of Marsh & McLennan Companies (NYSE:MRSH) on 9/14/2026.
• Sold $15,001 – $50,000 in shares of IQVIA (NYSE:IQV) on 9/14/2026.
• Sold $15,001 – $50,000 in shares of Home Depot (NYSE:HD) on 9/14/2026.
• Sold $1,001 – $15,000 in shares of Home Depot (NYSE:HD) on 9/14/2026.
• Sold $15,001 – $50,000 in shares of Emerson Electric (NYSE:EMR) on 9/14/2026.

IQVIA Stock Performance

IQVIA stock traded down $2.12 during midday trading on Tuesday, reaching $268.85. The stock had a trading volume of 398,830 shares, compared to its average volume of 1,726,363. The firm has a market capitalization of $44.25 billion, a PE ratio of 33.34, a P/E/G ratio of 2.31 and a beta of 1.18. IQVIA Holdings Inc. has a 12 month low of $154.50 and a 12 month high of $277.40. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 2.18. The firm’s 50-day moving average price is $250.32 and its 200 day moving average price is $203.63.

IQVIA (NYSE:IQV) last announced its quarterly earnings results on Tuesday, July 28th. The medical research company reported $3.15 EPS for the quarter, beating analysts’ consensus estimates of $3.03 by $0.12. IQVIA had a net margin of 8.10% and a return on equity of 30.25%. The company had revenue of $4.37 billion for the quarter, compared to analysts’ expectations of $4.30 billion. During the same period in the prior year, the company posted $2.81 EPS. IQVIA’s revenue was up 8.7% compared to the same quarter last year. IQVIA has set its FY 2026 guidance at 12.800-13.000 EPS. As a group, research analysts predict that IQVIA Holdings Inc. will post 11.56 earnings per share for the current fiscal year.

Institutional Trading of IQVIA

Institutional investors have recently added to or reduced their stakes in the business. BlackRock Inc. bought a new position in IQVIA during the second quarter valued at approximately $2,811,292,000. Geode Capital Management LLC boosted its stake in shares of IQVIA by 0.6% in the 4th quarter. Geode Capital Management LLC now owns 4,374,971 shares of the medical research company’s stock worth $982,272,000 after buying an additional 24,453 shares during the last quarter. Boston Partners grew its holdings in shares of IQVIA by 14.9% in the fourth quarter. Boston Partners now owns 4,087,380 shares of the medical research company’s stock worth $923,276,000 after acquiring an additional 530,672 shares during the period. JPMorgan Chase & Co. increased its position in IQVIA by 16.2% during the fourth quarter. JPMorgan Chase & Co. now owns 3,799,600 shares of the medical research company’s stock valued at $856,468,000 after acquiring an additional 528,753 shares during the last quarter. Finally, Norges Bank bought a new position in IQVIA in the fourth quarter valued at about $497,445,000. 89.62% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research firms recently weighed in on IQV. Stifel Nicolaus upped their target price on shares of IQVIA from $220.00 to $276.00 and gave the stock a “buy” rating in a report on Wednesday, July 29th. Weiss Ratings upgraded IQVIA from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday. Royal Bank Of Canada boosted their target price on IQVIA from $247.00 to $319.00 and gave the stock an “outperform” rating in a research report on Tuesday. Mizuho raised their price target on IQVIA from $215.00 to $230.00 and gave the company an “outperform” rating in a report on Monday, July 13th. Finally, Truist Financial restated a “buy” rating and issued a $329.00 price objective (up from $300.00) on shares of IQVIA in a research report on Monday. One investment analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, IQVIA presently has an average rating of “Moderate Buy” and an average target price of $257.75.

Insider Activity

In other IQVIA news, insider Keriann Cherofsky sold 558 shares of the company’s stock in a transaction that occurred on Wednesday, July 29th. The stock was sold at an average price of $245.21, for a total value of $136,827.18. Following the completion of the transaction, the insider directly owned 2,989 shares in the company, valued at $732,932.69. This represents a 15.73% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider James G. Berkshire sold 2,668 shares of the company’s stock in a transaction on Wednesday, September 2nd. The stock was sold at an average price of $261.33, for a total transaction of $697,228.44. Following the transaction, the insider owned 10,890 shares of the company’s stock, valued at approximately $2,845,883.70. This represents a 19.68% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 15,581 shares of company stock worth $3,796,021. Company insiders own 1.70% of the company’s stock.

About Representative Hern

Kevin Hern (Republican Party) is a member of the U.S. House, representing Oklahoma’s 1st Congressional District. He assumed office on November 13, 2018. His current term ends on January 3, 2027.

Hern (Republican Party) is running for re-election to the U.S. House to represent Oklahoma’s 1st Congressional District. He declared candidacy for the 2026 election.

Kevin Hern went into business as a McDonald’s franchisee in 1999. He acquired 10 McDonald’s franchises by 2012. He served on the McDonald’s National Leadership Team for 13 years, including the tax policy team, the insurance corporation, and as chairman of the economics team. From 2011 to 2015, he was chairman of the finance committee of the Oklahoma Turnpike Authority.

About IQVIA

IQVIA Holdings Inc (NYSE: IQV) is a global provider of technology, analytics and contract research services for the life sciences industry. The company helps pharmaceutical, biotechnology and medical device organizations develop products, manage clinical trials, understand healthcare markets and improve commercial performance.

IQVIA’s offerings include clinical research and trial management, real-world data and evidence, healthcare analytics, technology platforms, consulting, and commercial services such as sales support and patient engagement.